What Are Peptides? A Plain-Language Research Overview

Peptides are short chains of amino acids, the same building blocks that make up proteins. The distinction between a peptide and a protein is primarily length: peptides typically contain fewer than 50 amino acids linked together, while proteins are longer chains that fold into complex three-dimensional structures. At the smaller end of the scale, some biologically active peptides contain as few as two or three amino acids.

The word peptide comes from the Greek word peptos, meaning digested. Early peptide research was closely tied to understanding digestion, since many of the first peptides studied were fragments produced when proteins were broken down in the gut. The field has expanded enormously since then, and peptides are now recognized as one of the most ubiquitous classes of biological signaling molecules in the body.

How Peptides Work

Most peptides function as signaling molecules. They are produced in one location, travel through the bloodstream or act locally, bind to specific receptors on target cells, and trigger a defined biological response. The specificity of that interaction is one of the defining characteristics of peptides as a class: a given peptide typically binds to a limited set of receptor types, which means its effects are relatively targeted compared to many small-molecule drugs.

Receptors are proteins embedded in cell membranes that recognize and bind specific molecules. When a peptide binds to its receptor, it causes a conformational change in the receptor protein, which initiates an intracellular signaling cascade. Depending on the receptor and the cell type, this can result in changes to gene expression, enzyme activity, ion channel function, or a wide range of other cellular processes.

The body produces thousands of peptides with known biological roles. Hormones like insulin, glucagon, and GLP-1 are peptides. So are many neurotransmitter precursors, immune signaling molecules, and structural components of tissue. The catalog of naturally occurring peptides continues to expand as research tools improve.

Natural vs. Synthetic Peptides

Naturally occurring peptides are produced by the body through normal cellular machinery. The genes encoding them are transcribed into messenger RNA, which is then translated by ribosomes into amino acid chains. These chains are often further processed: cleaved to the correct length, modified with chemical groups, or folded into specific configurations that determine their activity.

Synthetic peptides are produced in laboratories using chemical synthesis methods, primarily solid-phase peptide synthesis (SPPS), a technique developed in the 1960s by Robert Bruce Merrifield, who received the Nobel Prize in Chemistry for the work in 1984. SPPS allows researchers to build peptide chains of defined sequence by attaching amino acids one at a time to a solid resin support. Modern automated synthesizers can produce peptides of 30 to 50 amino acids reliably and in quantities sufficient for research use.

Synthetic peptides used in research are typically analogs of naturally occurring sequences. They may be identical to the natural version, or modified to improve stability, extend half-life, or alter binding characteristics. The modifications matter because one of the challenges with peptide research is that unmodified peptides are often degraded quickly by enzymes in the blood and gut, limiting how long they remain active after administration.

Why Researchers Study Peptides

Several properties make peptides attractive as research tools and as potential therapeutic candidates.

Specificity. Because peptides bind to defined receptor sets, they can be designed to interact with a specific biological target without broadly affecting unrelated systems. This is a significant advantage over some small-molecule drugs, which can have wide-ranging off-target effects.

Biological compatibility. Peptides are structurally similar to compounds the body already produces. When they are metabolized, they break down into amino acids, which are then recycled through normal metabolic pathways rather than accumulating as foreign metabolites.

Range of targets. Peptides can interact with receptors, enzymes, ion channels, and intracellular proteins. This versatility means the class covers a wide range of potential research applications, from metabolic regulation to tissue repair to immune modulation.

Precision medicine potential. Because peptide-receptor interactions are highly specific, they offer a platform for interventions that are tailored to specific biological pathways, which aligns with the direction of modern pharmacological research toward targeted rather than systemic approaches.

Peptides vs. Proteins, Hormones, and Steroids

These terms are often used loosely in popular health discussions, and the distinctions are worth clarifying.

Proteins are large polypeptide chains, generally above 50 amino acids, that fold into three-dimensional structures. Peptides are shorter and typically do not fold in the same way. Some proteins are cleaved during processing to produce active peptide fragments, which is how several naturally occurring signaling peptides are generated.

Hormones are signaling molecules produced by endocrine glands that travel through the bloodstream to act on distant target tissues. Many hormones are peptides (insulin, GLP-1, glucagon), but some are steroids (cortisol, testosterone) or other molecule types (thyroid hormones). The category of peptide hormones is large and well-studied.

Steroids are a structurally distinct class of compounds built on a four-ring carbon scaffold. They include hormones like cortisol, estrogen, testosterone, and the anabolic steroids used in bodybuilding contexts. Steroids work through a fundamentally different mechanism than peptides: they typically cross cell membranes and bind to intracellular receptors that then act directly on gene expression. Peptides generally cannot cross cell membranes without a transporter and act primarily through surface receptors.

The practical implication of this distinction is that peptides and steroids have different risk profiles, different mechanisms of action, and different research histories. They are not interchangeable categories.

The Regulatory Landscape

In the United States, peptides occupy a complex regulatory space. Some peptides are FDA-approved drugs (semaglutide, insulin, oxytocin). Others are available through compounding pharmacies with a prescription. Others are sold for research purposes only and are not approved for human use. The category a given peptide falls into depends on its approval status, its scheduling under federal drug law, and periodic FDA reclassification actions.

The regulatory landscape shifted significantly in 2024 and 2026, when the FDA moved several peptides between compoundable and non-compoundable classifications. Anyone seeking to use peptides in a clinical context should verify current regulatory status with a licensed physician or pharmacist, as this information changes and varies by jurisdiction.